<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Clotting factor consumption and hypofibrinogenemia</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Clotting factor consumption and hypofibrinogenemia</h1>
<div class="graphic"><div class="figure"><div class="ttl">Clotting factor consumption and hypofibrinogenemia</div><div class="cntnt"><img src="data:jpeg;base64,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"/></div><div class="graphic_lgnd">Citrated rapid thromboelastography study (rapid-TEG) reflecting clotting factor consumption and hypofibrinogenemia. The red line indicates a normal study.<br/>This study shows a prolonged ACT, R time, and K time, reflecting enzymatic hypocoagulability; markedly low alpha angle, MA, and G, reflecting platelet hypocoagulability and poor fibrin deposition; and normal LY30.</div><div class="graphic_footnotes">R (reaction time): time from sample placement or activation until the tracing amplitude reaches 2 mm; K (clot formation time): time elapsed between the R-time and the point where the tracing amplitude reaches 20 mm; alpha angle: angle between the middle line of the tracing and a tangential line to the developing "body" of the tracing; MA (maximal amplitude): the maximal amplitude reached after clot initiation; G: a calculated measure of total clot strength based on amplitude; LY30: the amount of clot lysis detected 30 minutes after the maximal amplitude (MA) is reached; SP (split point): time from sample placement (or activation with an exogenous procoagulant) until the earliest detectable resistance.</div><div id="graphicVersion">Graphic 60690 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
